What Is a Lesion in a Heart Artery and How Is It Treated?

A lesion in a heart artery is any abnormal change in the wall of a coronary artery, the vessels that feed blood to the heart muscle itself. The most common type by far is an atherosclerotic plaque, a buildup of fat, fibrous tissue, and calcium that grows inside the artery wall over years or decades. But not every coronary lesion is a plaque, and not every plaque behaves the same way. The distinction between a quiet, stable lesion and one on the verge of causing a heart attack shapes every treatment decision that follows.

How Atherosclerotic Lesions Form

Atherosclerosis begins when the inner lining of an artery gets damaged or activated, often by high blood pressure, high cholesterol, smoking, or chronic inflammation. Once the lining is disrupted, fats and immune cells start accumulating beneath it, triggering a chain reaction of lipid buildup, fibrous tissue growth, and eventually calcium deposits.¹ This process unfolds over years, often beginning in adolescence and silently progressing through middle age.

Where a plaque forms is not random. Arteries branch and curve, and at those branch points blood flow slows and swirls rather than streaming smoothly. Researchers have found that plaques preferentially develop in areas of low wall shear stress, the drag force that flowing blood exerts on the vessel lining. Low shear stress promotes plaque growth, while high shear stress tends to protect against it.² This is why certain spots, like the origin of the left anterior descending artery, are such frequent trouble zones.

What Plaques Are Made Of

A mature coronary plaque is not a uniform glob of fat. Autopsy and imaging studies break plaques into several components: fibrous tissue, fatty debris (sometimes called a necrotic or lipid core), calcified deposits, and foam cells (immune cells engorged with cholesterol). In very elderly patients, fibrous tissue dominates, making up roughly 87% of plaque area on average, with calcium and lipid debris accounting for smaller fractions.³ The mix matters because it determines how the plaque behaves.

As a plaque grows and narrows the artery further, the composition shifts. Severely narrowed segments contain dramatically more lipid debris and calcium compared to mildly narrowed ones, while the proportion of fibrous tissue drops.³ Modern CT imaging can now distinguish lipid-rich lesions from more fibrous or calcified ones, and it can detect positive remodeling, a pattern where the artery wall bulges outward to accommodate the plaque.⁴ That distinction has direct clinical importance.

Why Some Plaques Cause Heart Attacks and Others Don’t

The plaques most likely to cause a heart attack are often not the ones causing the tightest narrowing. A so-called vulnerable plaque has a thin fibrous cap over a large pool of lipid-rich material. If that cap tears, the lipid core is exposed to the bloodstream, triggering a clot that can block the artery within minutes. These vulnerable plaques are frequently only moderately narrowed and invisible on a standard angiogram.⁵

This is one of the more unsettling facts about coronary artery disease: the lesion that barely shows up on an imaging test can be more dangerous than one blocking 80% of the artery. A stable, heavily calcified plaque with a thick fibrous cap may cause chest pain on exertion but is far less likely to rupture suddenly. Researchers are actively looking for ways to identify vulnerable plaques before they cause trouble. One line of investigation has found that a specific circulating molecule, miR-146a, is present at significantly higher levels in patients whose plaques are vulnerable compared to those with stable plaques.⁶ A blood test for plaque vulnerability would be a major step, though this remains under study.

Lesions That Aren’t Atherosclerosis

Not every coronary artery lesion is caused by cholesterol buildup. Spontaneous coronary artery dissection, or SCAD, occurs when the layers of the artery wall separate, allowing blood to pool between them and narrow or block the vessel. It is an important cause of heart attacks and sudden death, particularly among young women and people who have none of the usual risk factors for heart disease. SCAD is associated with pregnancy, physical and emotional stress, and underlying arterial conditions like fibromuscular dysplasia.⁷ Treatment for SCAD is fundamentally different from treatment for atherosclerotic plaques, since stenting a dissected artery can sometimes make things worse.

Another category involves the tiny vessels downstream of the main coronary arteries. In coronary microvascular dysfunction, the large arteries may look completely normal on an angiogram, but the smallest branches are not dilating properly. Patients experience real chest pain, and their risk is not trivial: registry data show that patients with microvascular dysfunction have roughly four times the risk of major cardiac events compared to people without it, and they use substantially more healthcare resources.⁸ Management tends to center on anti-ischemic medications and exercise rather than stents or surgery.⁹

How Lesions Are Found and Measured

The traditional tool for seeing coronary lesions is invasive coronary angiography: a catheter threaded into the coronary arteries, with dye injected to outline the vessel on X-ray. It shows where the artery is narrowed, but it has real limitations. A recent study found that when angiography was compared to cardiac MRI measurements of actual blood flow to the heart muscle, the angiogram’s ability to detect truly reduced blood flow was poor, with a sensitivity of only about 36%.¹⁰ Roughly two-thirds of vessel territories with meaningfully reduced blood flow had narrowings that looked non-significant on the angiogram.

To get more detail, cardiologists can use imaging probes placed directly inside the artery during catheterization. Intravascular ultrasound (IVUS) uses sound waves to create cross-sectional images of the vessel wall, revealing plaque size and composition. Optical coherence tomography (OCT) uses light and produces images with much finer resolution, allowing doctors to see thin fibrous caps and tiny features that IVUS misses.¹¹ OCT measurements are also more reproducible than IVUS measurements, with roughly half the measurement variability in head-to-head testing.¹²

Beyond imaging, doctors often need to know whether a lesion is actually starving the heart muscle of blood. Fractional flow reserve (FFR) measures the pressure drop across a narrowing during maximum blood flow. A related technique, the instantaneous wave-free ratio (iFR), can provide similar information without needing a drug to maximally dilate the arteries. A hybrid approach that starts with iFR and reserves FFR for borderline cases can match the accuracy of FFR alone in roughly 94% of lesions while avoiding the extra drug step in over half of patients.¹³

Medical Treatment for Coronary Lesions

Medication is the foundation for treating coronary artery disease, whether or not a procedure is planned. The primary goal of drug therapy is twofold: shrink or stabilize existing plaques and prevent clots from forming on them.

Statins are the first-line drugs for lowering LDL cholesterol and stabilizing plaques. For patients who cannot get their cholesterol low enough on statins alone, a newer class of drugs called PCSK9 inhibitors can be added. A meta-analysis found that adding a PCSK9 inhibitor to statin therapy significantly improved multiple markers of plaque health: it reduced plaque volume, thickened the fibrous cap (making the plaque less rupture-prone), shrank the lipid core, and reduced the degree of arterial narrowing.¹⁴ In the PACMAN-AMI trial specifically, one year of treatment with the PCSK9 inhibitor alirocumab on top of high-intensity statins shrank total plaque volume by about twice as much as statins alone.¹⁵

Antiplatelet drugs are the other essential leg of medical therapy. Platelets are the blood cells that form clots, and if a plaque ruptures, it’s the platelet-driven clot that actually blocks the artery. In patients with established coronary disease, antiplatelet treatment reduces the risk of a serious cardiovascular event by roughly a quarter.¹⁶ After a heart attack or after stent placement, guidelines typically call for two antiplatelet drugs together for a period of months to a year, because a single drug is not enough to prevent clots during the highest-risk window.¹⁷ In patients without any documented events or angiographic disease, the evidence for antiplatelet therapy is much weaker and comes with meaningful bleeding risk, so it is generally not recommended for primary prevention.¹⁷

Stents and Other Catheter-Based Procedures

When a lesion is causing significant symptoms or putting the heart muscle at immediate risk, cardiologists can treat it through the same catheter used for diagnosis. A balloon at the catheter tip is inflated inside the narrowed segment to compress the plaque, and a stent, a tiny metal mesh tube, is left behind to keep the artery open. Early balloon-only angioplasty had problems with the artery snapping back shut or closing abruptly, which led to the development of metal stents. Those bare-metal stents solved the recoil problem but introduced a new one: the body’s healing response sometimes overgrew the stent interior, a process called in-stent restenosis. Drug-eluting stents, coated with medication that slows tissue growth, largely addressed this and became the standard of care.¹⁸

Heavily calcified lesions pose a special challenge because they resist balloon expansion. Several tools exist to crack or shave the calcium before a stent can be placed. Rotational atherectomy uses a diamond-tipped burr to grind through calcium. Intravascular lithotripsy uses shockwaves, similar in concept to kidney stone treatment, to fracture the calcium from inside. In the first randomized trial comparing these approaches, lithotripsy proved noninferior to rotational atherectomy for achieving adequate stent expansion.¹⁹ Having multiple options matters because the ideal technique depends on the location and extent of the calcium.

When stents are placed in complex lesions, imaging guidance from inside the artery improves outcomes. A large randomized trial comparing OCT-guided and IVUS-guided stenting in complex coronary lesions found similar rates of death, heart attack, and the need for repeat procedures over two years of follow-up. OCT-guided procedures did have a lower rate of major procedural complications.²⁰

When Bypass Surgery Is the Better Choice

Coronary artery bypass grafting (CABG) reroutes blood around blocked segments using vessels harvested from the chest, leg, or arm. It is a major operation, but for certain patterns of disease it offers better long-term outcomes than stenting. In patients with multivessel disease involving the proximal left anterior descending artery, bypass surgery has been associated with lower rates of the combined outcome of death, heart attack, or stroke compared to stenting with drug-eluting stents at five years.²¹

The picture is more nuanced when you factor in completeness of revascularization, meaning whether all significant blockages were successfully treated. A pooled analysis of major trials found that when stenting achieved complete revascularization, long-term survival was similar to bypass surgery with complete revascularization.²² The practical implication is that the ability to treat all lesions successfully is at least as important as the method used. Heart teams, which typically include a cardiologist and a cardiac surgeon, now jointly review complex cases to recommend the approach most likely to achieve complete treatment.

Can Lifestyle Changes Reverse Coronary Lesions?

One of the more striking findings in cardiology comes from trials that tested aggressive lifestyle modification alone, without cholesterol-lowering drugs. In the Lifestyle Heart Trial, patients assigned to a program of a very-low-fat vegetarian diet, smoking cessation, stress management, and moderate exercise showed measurable regression of their coronary artery narrowings within one year. Average stenosis dropped from 40% to about 38% in the intervention group while worsening from roughly 43% to 46% in controls.²³ Five years later, the intervention group continued to improve, while the control group’s lesions progressed substantially, worsening by about 12 absolute percentage points.²⁴

These numbers are small in absolute terms, and the lifestyle changes demanded were far more rigorous than what most people sustain. But the direction of the finding is important: coronary artery disease is not a one-way street. The combination of aggressive medical therapy with as much lifestyle change as a patient can realistically maintain remains the backbone of long-term management, regardless of whether a stent or bypass was performed.

Detecting Trouble Before Plaques Rupture

Much current research aims to identify dangerous lesions earlier, before they declare themselves with a heart attack. One promising approach looks not at the plaque itself but at the fat surrounding the coronary arteries. The fat attenuation index (FAI), derived from a standard coronary CT scan, measures changes in the tissue around the artery that reflect underlying inflammation in the vessel wall.²⁵ When a coronary artery is inflamed, it releases chemical signals that alter the fat cells nearby, preventing them from accumulating lipid normally. Those changes in fat composition are visible on CT. In validation studies, the FAI was able to detect subclinical coronary disease and to pick up dynamic changes in vascular inflammation, including the inflamed plaques seen during acute coronary events.²⁶

This is an area where the science is genuinely moving fast. If techniques like the FAI prove reliable enough for routine clinical use, they could shift the focus from treating blockages after they cause symptoms to identifying and stabilizing dangerous plaques years earlier. For now, the practical advice remains straightforward: manage the risk factors that drive plaque formation and instability. Control blood pressure, lower LDL cholesterol as much as the evidence warrants, stay physically active, and don’t smoke. The lesion itself, whether it’s a small fatty streak or a heavily calcified blockage, is the downstream result of those upstream forces.